Advertisement

Management of Esophageal Cancer

  • Kyle A. Perry
  • John G. Hunter
Chapter

Abstract

The incidence of esophageal adenocarcinoma is rapidly increasing, with a 350% increase in its incidence since 1970 [1–3]. Currently, the number of new cases of esophageal cancer in the United States is estimated at 16,400 per year, with over half of these being esophageal adenocarcinoma [4]. Esophageal cancer is associated with a dismal overall 5-year survival of less than 15%; however, when detected early and confined to the esophagus, the 5-year survival can be as high as 85%, highlighting the need for early detection, thorough preoperative evaluation, and accurate clinical staging [4–6].

Keywords

Esophageal Cancer Endoscopic Mucosal Resection Esophageal Adenocarcinoma Minimally Invasive Esophagectomy Freeze Section Analysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Gopal DV, Jobe BA (2002) Screening for Barrett’s esophagus may not reduce morbidity and mortality due to esophageal adenocarcinoma – Commentary. Evid Based Oncol 3:144–145CrossRefGoogle Scholar
  2. 2.
    Spechler SJ (2002) Clinical practice: Barrett’s Esophagus. N Engl J Med 346:836–842PubMedCrossRefGoogle Scholar
  3. 3.
    Spechler SJ (2001) Screening and surveillance for complications related to gastroesophageal reflux disease. Am J Med 111:130S–136SPubMedCrossRefGoogle Scholar
  4. 4.
    Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96PubMedCrossRefGoogle Scholar
  5. 5.
    el-Serag HB (2002) The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 31:421–440PubMedCrossRefGoogle Scholar
  6. 6.
    Nigro J, DeMeester S, Hagen J et al (1999) Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 117:960–968PubMedCrossRefGoogle Scholar
  7. 7.
    Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825–831PubMedCrossRefGoogle Scholar
  8. 8.
    Jobe BA, Enestvedt CK, Thomas CR Jr. (2006) Disease-specific multidisciplinary care: a natural progression in the management of esophageal cancer. Dis Esophagus 19:417–418PubMedCrossRefGoogle Scholar
  9. 9.
    Blazeby JM, Wilson L, Metcalfe C, Nicklin J, English R, Donovan JL (2006) Analysis of clinical decision-making in multi-disciplinary cancer teams. Ann Oncol 3:457–460CrossRefGoogle Scholar
  10. 10.
    Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137PubMedCrossRefGoogle Scholar
  11. 11.
    Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984PubMedCrossRefGoogle Scholar
  12. 12.
    Swanstrom LL, Hanson P (1997) Laparoscopic total esophagectomy. Arch Surg 132:943–949PubMedCrossRefGoogle Scholar
  13. 13.
    Luketich JD, Alvelo-Rivera M, Buenaventura PO et al (2003) Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238:486–495PubMedGoogle Scholar
  14. 14.
    Jobe BA, Kim CY, Minjarez RC, O’Rourke R, Chang EY, Hunter JG (2006) Simplifying minimally invasive transhiatal esophagectomy with the inversion approach: lessons learned from the first 20 cases. Arch Surg 141:857–866PubMedCrossRefGoogle Scholar
  15. 15.
    Esophagus. American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edn. Lippincott-Raven Publishers, Philadelphia, pp 65–69Google Scholar
  16. 16.
    Ellis FH, Heatley GJ, Krosna MJ, Williamson WA, Balogh K (1997) Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive 8 year time intervals, using improved staging criteria. J Thorac Cardiovasc Surg 113:836PubMedCrossRefGoogle Scholar
  17. 17.
    Iizuka T, Isono K, Kakegawa T, Watanabe H (1989) Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese committee for registration of esophageal carcinoma cases. Chest 96:c1005–c1011CrossRefGoogle Scholar
  18. 18.
    Korst RJ, Rusch VW, Venkatraman E et al (1998) Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115:660–670PubMedCrossRefGoogle Scholar
  19. 19.
    Puli RS, Reddy JBK, Bechtold ML, Antillon D, Ibdah JA, Antillon MR (2008) Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 14:1479–1490PubMedCrossRefGoogle Scholar
  20. 20.
    Takashima S, Takeuchi N, Shiozaki H et al (1991) Carcinoma of the esophagus: CT vs. MR imaging in determining resectability. Am J Roentgenol 156:297–302Google Scholar
  21. 21.
    Quint LE, Glazer GM, Orringer MB (1985) Esophageal imaging by MR and CT: study of normal anatomy and neoplasms. Radiology 156:727–731PubMedGoogle Scholar
  22. 22.
    Lehr L, Rupp N, Siewert JR (1988) Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging. Surgery 103:344–350PubMedGoogle Scholar
  23. 23.
    Luketich J, Schauer P, Meltzer C et al (1997) Role of positron emission tomography in staging the patient with esophageal cancer. Ann Thorac Surg 64:765–769PubMedCrossRefGoogle Scholar
  24. 24.
    Luketich J, Freidman D, Weigel T et al (1999) Evaluation of distant metastases in esophageal cancer: 100 consecutive PET scans. Ann Thorac Surg 68:1133–1137PubMedCrossRefGoogle Scholar
  25. 25.
    Suntharalingam M, Mougham J, Coia LR et al (1999) The national practice for patients receiving radiation therapy for carcinoma of the esophagus: results of the 1996–1999 patterns of care study. Cancer 85:2499–2505CrossRefGoogle Scholar
  26. 26.
    Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1974–1984CrossRefGoogle Scholar
  27. 27.
    Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727–1733CrossRefGoogle Scholar
  28. 28.
    Ancona E, Ruol A, Santi S et al (2001) Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients respectable esophageal squamous cell carcinoma: final report of a randomised trial of preoperative chemotherapy versus surgery alone. Cancer 91:2165–2174PubMedCrossRefGoogle Scholar
  29. 29.
    Geh JI, Crellin AM, Glynne-Jones R (2001) Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 88:338–356PubMedCrossRefGoogle Scholar
  30. 30.
    Reynolds JV, Muldoon C, Hollywood D et al (2007) Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 245:707–716PubMedCrossRefGoogle Scholar
  31. 31.
    Kodama M, Kakegawa T (1998) Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123:432–439PubMedCrossRefGoogle Scholar
  32. 32.
    Soetikno R, Kaltenbach T, Yeh R, Gotoda T (2005) Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 23:4490–4498PubMedCrossRefGoogle Scholar
  33. 33.
    Ell C, May A, Pech O, Gossner L et al (2007) Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 65:3–10PubMedCrossRefGoogle Scholar
  34. 34.
    Katada C, Muto M, Manabe T, Ohtsu A, Yoshida S (2005) Local recurrence of squamous-cell carcinoma of the esophagus after EMR. Gastrointest Endosc 61:219–225PubMedCrossRefGoogle Scholar
  35. 35.
    Conio M, Repici A, Cestari R et al (2005) Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett’s esophagus: an Italian experience. World J Gastroenterol 11:6650–6655PubMedGoogle Scholar
  36. 36.
    Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137PubMedCrossRefGoogle Scholar
  37. 37.
    Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984PubMedCrossRefGoogle Scholar
  38. 38.
    Cuschieri A, Shimi S, Banting S (1992) Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37:7–11PubMedGoogle Scholar
  39. 39.
    DePaula AL, Hashiba K, Ferreira EA, de Paula RA, Grecco E (1995) Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc Percut Tech 5:1–5Google Scholar
  40. 40.
    Law S, Fok M, Chu KM, Wong J (1997) Thoracoscopic esophagectomy for esophageal cancer. Surgery 122:8–14PubMedCrossRefGoogle Scholar
  41. 41.
    Nguyen NT, Follette DM, Wolfe BM, Schneider PD, Roberts P, Goodnight JE Jr. (2000) Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch Surg 135:920–925PubMedCrossRefGoogle Scholar
  42. 42.
    Nguyen NT, Roberts P, Follette DM, Rivers R, Wolfe BM (2003) Thoracoscopic and laparoscopic esophagectomy for benign and malignant disease: lessons learned from 46 consecutive procedures. J Am Coll Surg 197:902–913PubMedCrossRefGoogle Scholar
  43. 43.
    Luketich JD, Alvelo-Rivera M, Buenaventura PO et al (2003) Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238:486–495PubMedGoogle Scholar
  44. 44.
    Avital S, Zundel N, Szomstein S, Rosenthal R (2005) Laparoscopic transhiatal esophagectomy for esophageal cancer. Am J Surg 190:69–74PubMedCrossRefGoogle Scholar
  45. 45.
    Luketich JD, Nguyen NT, Schauer PR (1998) Laparoscopic transhiatal esophagectomy for Barrett’s esophagus with high-grade dysplasia. JSLS 2:75–77PubMedGoogle Scholar
  46. 46.
    Sadanaga N, Kuwano H, Watanabe M et al (1994) Laparoscopy-assisted surgery: a new technique for transhiatal esophageal dissection. Am J Surg 168:355–357PubMedCrossRefGoogle Scholar
  47. 47.
    Swanstrom LL, Hanson P (1997) Laparoscopic total esophagectomy. Arch Surg 132:943–949PubMedCrossRefGoogle Scholar
  48. 48.
    Akiyama H, Tsurumaru M, Ono Y, Udagawa H, Kajiyama Y (1994) Esophagectomy without thoracotomy with vagal preservation. J Am Coll Surg 178:83–85PubMedGoogle Scholar
  49. 49.
    Jobe BA, Kim CY, Minjarez RC, O’Rourke R, Chang EY, Hunter JG (2006) Simplifying minimally invasive transhiatal esophagectomy with the inversion approach: lessons learned from the first 20 cases. Arch Surg 141:857–866PubMedCrossRefGoogle Scholar
  50. 50.
    Perry KA, Enestvedt CK, Teicher N, Hunter JG (2008) Short term outcomes of minimally invasive esophagectomy: laparoscopic inversion esophagectomy versus combined laparoscopic-thoracoscopic approach (abstract). European Association of Endoscopic Surgeons, StockholmGoogle Scholar
  51. 51.
    Omloo JM, Lagarde SM, Hulscher JB et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus. Ann Surg 246:992–1001PubMedCrossRefGoogle Scholar
  52. 52.
    Heit HA, Johnson LF, Siegel SR, Boyce HW Jr. (1978) Palliative dilation for dysphagia in esophageal carcinoma. Ann Intern Med 89:629–631PubMedGoogle Scholar
  53. 53.
    Hernandez LV, Jacobson JW, Harris MS (2000) Comparison among the perforation rates of Maloney, balloon, and Savary dilation of esophageal strictures. Gastrointest Endosc 51:460–462PubMedCrossRefGoogle Scholar
  54. 54.
    Ellul JP, Watkinson A, Khan RJ, Adam A, Mason RC (1995) Self-expanding metal stents for the palliation of dysphagia due to inoperable oesophageal carcinoma. Br J Surg 82:1678–1681PubMedCrossRefGoogle Scholar
  55. 55.
    Cowling MG, Hale H, Grundy A (1998) Management of malignant oesophageal obstruction with self-expanding metallic stents. Br J Surg 85:264–266PubMedCrossRefGoogle Scholar
  56. 56.
    Ell C, May A (1997) Self-expanding metal stents for palliation of stenosing tumors of the esophagus and cardia: a critical review. Endoscopy 29:392–398PubMedCrossRefGoogle Scholar
  57. 57.
    Morgan RA, Ellul JP, Denton ER, Glynos M, Mason RC, Adam A (1997) Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology 204:527–532PubMedGoogle Scholar
  58. 58.
    Mayoral W, Fleischer D, Salcedo J et al (2000) Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc 51:556–559PubMedCrossRefGoogle Scholar
  59. 59.
    Buset M, Dunham F, Baize M, de Toeuf J, Cremer M (1983) Nd-YAG laser, a new palliative alternative in the management of esophageal cancer. Endoscopy 15:353–356PubMedCrossRefGoogle Scholar
  60. 60.
    Alexander GL, Wang KK, Ahlquist DA et al (1994) Does performance status influence the outcome of Nd:YAG laser therapy of proximal esophageal tumors? Gastrointest Endosc 40:451–454PubMedCrossRefGoogle Scholar
  61. 61.
    Bisgaard T, Wojdemann M, Heindorff H, Svendsen LB (1997) Nonsurgical treatment of esophageal perforations after endoscopic palliation in advanced esophageal cancer. Endoscopy 29:155–159PubMedCrossRefGoogle Scholar
  62. 62.
    Mellow MH, Pinkas H (1984) Endoscopic therapy for esophageal carcinoma with Nd:YAG laser: prospective evaluation of efficacy, complications, and survival. Gastrointest Endosc 30:334–339PubMedCrossRefGoogle Scholar
  63. 63.
    Marcon NE (1994) Photodynamic therapy and cancer of the esophagus. Semin Oncol 21:20–23PubMedGoogle Scholar
  64. 64.
    Lightdale CJ, Heier SK, Marcon NE et al (1995) Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42:507–512PubMedCrossRefGoogle Scholar
  65. 65.
    Ilson DH, Saltz L, Enzinger P et al (1999) Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 17:3270–3275PubMedGoogle Scholar
  66. 66.
    Ilson DH, Forastiere A, Arquette M et al (2000) A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J 6:316–323PubMedGoogle Scholar
  67. 67.
    Spiridonidis CH, Laufman LR, Jones J et al (1998) Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies. J Clin Oncol 16:3866–3873PubMedGoogle Scholar
  68. 68.
    Tebbutt NC, Norman A, Cunningham D et al (2002) A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer. Ann Oncol 13:1568–1575PubMedCrossRefGoogle Scholar
  69. 69.
    O’Rourke IC, Tiver K, Bull C, Gebski V, Langlands AO (1988) Swallowing performance after radiation therapy for carcinoma of the esophagus. Cancer 61:2022–2026PubMedCrossRefGoogle Scholar
  70. 70.
    Sur RK, Donde B, Levin VC, Mannell A (1998) Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys 40:447–453PubMedCrossRefGoogle Scholar
  71. 71.
    Hunter JG (2010) Atlas of minimally invasive surgical operations. Philadelphia, PA: McGraw-HillGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Kyle A. Perry
    • 1
  • John G. Hunter
    • 1
  1. 1.Department of SurgeryOregon Health and Sciences UniversityPortlandUSA

Personalised recommendations